pneumonia

pneumoniajourn

Vol7SpecialIssueforweb

EuroPneumo Special Issue / pneumonia 2015 Oct 21;7:I–72

Tn5253 affects the transposition rate, which is decreased or abolished when it is integrated in an alternative attB.

P1.36

Mutagenesis of one Streptococcus pneumoniae serotype 1 strain

Vanessa Terra 1 , Charles Plumptre 2 , Emily Kay 1 , Brendan Wren 1

1

London School of Hygiene and Tropical Medicine, London, UK; 2 University College London, London, UK

Streptococcus pneumoniae causes pneumonia, bacteraemia, meningitis and otitis media. Despite vaccination, there

are still around 1 million deaths each year worldwide. Serotype 1 is amongst the most invasive of serotypes and is

extremely important in Africa. It is also a significant cause of meningitis, is unusual in that it is rarely found colonising

the nasopharynx, and is frequently associated with outbreaks. Although included in the pneumococcal conjugate

vaccine, PCV13, the efficacy against serotype 1 has been questioned. Therefore there is a continuous need to study and

understand this particular serotype. In this study, a new method was developed to mutagenise a serotype 1 strain. The

method relies on: the known natural competence of S. pneumoniae; double recombination; and a delivery plasmid. The

delivery plasmid contains a PCR fragment where a portion of the gene of interest has been deleted and substituted by

a suitable antibiotic cassette. This is followed by natural transformation. In order to test the method, 3 genes known to

be possible to mutate and 1 putative gene were targeted and the mutations achieved. The loss of function mutants will

be firstly studied in the insect larvae model Galleria mellonella, for decreased virulence, followed by virulence studies in

mice. The ability to mutagenise this strain will help pave the way for a better and more extensive understanding of such

an important serotype, allowing for improved therapies and better vaccines.

P1.37

Improving molecular detection, identification and serotyping of

Streptococcus pneumoniae in complex samples

Laura Boelsen 1, 2 , Eileen Dunne 1 , Katherine Gould 3 , Fiona Russell 1, 4 , Kim Mulholland 1, 5 , Jason

Hinds 3 , Catherine Satzke 1, 6

1

Pneumococcal Research, Murdoch Childrens Research Institute, Parkville, VIC, Australia; 2 Department of Paediatrics, The University of Melbourne,

Parkville, VIC, Australia; 3 Bacterial Microarray Group, St. George’s University of London, London, UK; 4 Centre for International Child Health,

Department of Paediatrics, The University of Melbourne, Parkville, VIC, Australia; 5 London School of Hygiene and Tropical Medicine, London, UK;

6

Department of Microbiology and Immunology, Doherty Institute for Infection and Immunity, The University of Melbourne, Parkville, VIC, Australia

Molecular methods (lytA qPCR and serotyping by microarray) were used to examine pneumococcal carriage in adult

caregivers using nasopharyngeal and oropharyngeal (OP) samples collected as part of a PCV10 impact study in Fiji. Results

for the OP samples were more difficult to interpret, as microarray analysis indicated many samples contained partial or

divergent pneumococcal capsule homologues but also lacked pneumococci, including several lytA positive samples. False

positives in OP samples due to the presence of capsule and lytA gene homologues in non-pneumococcal species have

been reported by other groups. Culture of OP samples on gentamicin horse blood agar (gHBA) also revealed a complex

mix of bacteria present. Here we dissect the complexity of a subset of these OP samples to better understand the

component species present and to improve the sample screening approach by investigating alternative pneumococcalspecific

qPCR targets. A representative of each colony morphology on gHBA was subcultured from 11 samples resulting

in 92 isolates. Each isolate was tested by standard culture-based pneumococcal identification tests and MALDI-TOF/

MS for species identification. A subset were analysed by microarray and serotyped by latex agglutination. Preliminary

results have found 3 serotypeable pneumococcal isolates, and 9 non-pneumococcal isolates with latex agglutination

serotyping results, most commonly 19B (n = 6). MALDI-TOF/MS (n = 13) identified Streptococcus mitis/Streptococcus

oralis (n = 7), Streptococcus salivarius (n = 2), Streptococcus parasanguinis (n = 2) and Streptococcus anginosus (n = 1),

with 1 unidentified isolate. The MALDI-TOF/MS results were concordant with microarray analysis, which also found

non-pneumococcal isolates containing pneumococcal capsule gene homologues. Some non-pneumococcal isolates

were weakly positive for lytA and likely contributing to the weak positivity of some OP samples. Our results thus far

highlight the complexity of OP samples and the potential to misidentify and incorrectly serotype pneumococci using

existing conventional and molecular methods. Further work examining the performance of alternative pneumococcal

identification qPCR screening targets is underway.

pneumonia 2015 Volume 7

21

Similar magazines